MYX · Mayne Pharma Group Ltd.
6.01
AUDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
AU$262.87M
PE
9.10
EV/EBITDA
8.6
DIV Yield
0%
Franking
100%
MQV Rating
5Very Weak
As at 17/11/2026 04:12:36 PM
Price StockChart
Description
- All-Companies
- All-Consensus
- EMA 125 Breakup
- GROWTH AUS
- HALO Balance Sheet
- HALO Earnings Momentum
- HALO Momentum
- HALO Ords
- HALO Price Momentum
Key Fundamentals
EPS 3 yr Growth
-107.90%
EBITDA Margin
7.80%
Operating Cashflow
$16m
Free Cash Flow Return
4.10%
ROIC
8.20%
Interest Coverage
5.60
Quick Ratio
1.10
Performance
52 weeks range
Low 2.04 - 6.04
Trade Value (12mth)
AU$262,502.00
1 week
-1.83%
1 month
25.88%
YTD
0.63%
1 year
-44.56%
All time high
37.10
Additional Data
Shares Outstanding (Fully Diluted)
95m
HALO Sector
Healthcare
Next Company Report Date
26-Aug-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
AUD
Short Sell (% of issue)
2.37
Health Scores
Short Term
Mean Reversion
Very Weak
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Strong
Earnings
Very Strong
Growth
Earnings
Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Strong
Valuation
News & Announcements
| Date | Event |
17 November 26ASXD | |
17 November 26ASXD | |
17 November 26ASXD | |
16 November 26ASXD | |
06 November 26ASXD |
Key Stakeholders
| Name | Title |
| Bruce L. Mathieson | Individual |
| UBS Group AG | Public Company |
| Ivl Group Ltd. | Private Company |
| Narlack Pty Ltd. | Private Company |
| Roger Campbell Corbett | Individual |